|By Marketwired .||
|September 3, 2014 06:15 AM EDT||
REDWOOD CITY, CA -- (Marketwired) -- 09/03/14 -- Cervel Neurotech, Inc., a privately held company pioneering a non-invasive and non-pharmacologic treatment for depression, pain and other conditions, today announced the achievement of primary and secondary endpoints in a feasibility study of its multicoil repetitive transcranial magnetic stimulation (rTMS) system for patients suffering from depression. The Hamilton Rating Scale for Depression (HAMD), a scientifically validated tool for measuring depression severity and widely considered the gold standard, was used to assess the clinical endpoints in the randomized, sham-controlled, double blind study.
"We are extremely pleased with the results from our feasibility study as it supports the effectiveness of our multicoil approach for treating specific brain circuits responsible for depression symptoms," said Eric Meier, chief executive officer of Cervel Neurotech. "The Cervel System produced a fast and strong antidepressant effect.
Depression is a devastating condition for patients and their loved ones, and medication therapy alone is either not effective or poorly tolerated for a significant percentage of patients," continued Meier. "Our immediate focus will be completion of a pivotal study and the other requirements for marketing clearance."
The primary endpoint was the average change in HAMD scores from treatment start to finish, comparing patients receiving real rTMS and those receiving sham (placebo) treatment. Data analyzed from 86 patients at five sites demonstrated a statistically significant advantage in average score improvement for the rTMS group. Throughout the study, there were no serious device-related adverse events.
As a secondary study endpoint, the proportion of patients responding well to treatment was measured in each group, with treatment responders defined as patients whose HAMD depression symptoms were reduced by at least 50 percent. In the Cervel study, the proportion of patients receiving real rTMS who met the responder definition was almost twice that of the sham group. Moreover, the difference in response rates between the real and sham rTMS groups achieved statistical significance.
Certain central nervous system conditions, such as depression and pain, are thought to occur because of disordered metabolic activity in a network of regions within different brain circuits. TMS involves using pulsed magnetic fields to create small electrical currents that stimulate those areas to restore metabolism. Cervel's proprietary approach uses multiple magnetic fields, generated by coils placed on a patient's scalp, to selectively stimulate both superficial and deeper brain regions, to relieve the symptoms of the associated condition.
Depression remains one of the most common and disabling mental illnesses affecting 16 million adults in the United States (US) alone, according to the National Institute of Mental Health. Despite undergoing treatment with antidepressant medications, approximately four-and-a-half million people either do not respond to or cannot tolerate the side effects of their medications. The Cervel feasibility study included subjects from both of these classifications.
About the Cervel Neurotech System
The Cervel System is an investigational device, limited by US law to investigational use only. Visit www.cervel.com for more information.
Cervel Neurotech, Inc.
Oct. 23, 2016 02:15 AM EDT Reads: 973
Oct. 23, 2016 02:15 AM EDT Reads: 523
Oct. 23, 2016 02:00 AM EDT Reads: 10,955
Oct. 23, 2016 01:45 AM EDT Reads: 663
Oct. 23, 2016 01:45 AM EDT Reads: 3,808
Oct. 23, 2016 01:30 AM EDT Reads: 1,025
Oct. 23, 2016 01:30 AM EDT Reads: 3,641
Oct. 23, 2016 01:15 AM EDT Reads: 879
Oct. 23, 2016 01:15 AM EDT Reads: 982
Oct. 23, 2016 12:45 AM EDT Reads: 3,519
Oct. 23, 2016 12:15 AM EDT Reads: 2,428
The Open Connectivity Foundation (OCF), sponsor of the IoTivity open source project, and AllSeen Alliance, which provides the AllJoyn® open source IoT framework, today announced that the two organizations’ boards have approved a merger under the OCF name and bylaws. This merger will advance interoperability between connected devices from both groups, enabling the full operating potential of IoT and representing a significant step towards a connected ecosystem.
Oct. 23, 2016 12:00 AM EDT Reads: 1,188
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Eric Robertson, General Manager at CollabNet, will discuss how customers are able to achieve a level of transparency that e...
Oct. 23, 2016 12:00 AM EDT Reads: 797
Donna Yasay, President of HomeGrid Forum, today discussed with a panel of technology peers how certification programs are at the forefront of interoperability, and the answer for vendors looking to keep up with today's growing industry for smart home innovation. "To ensure multi-vendor interoperability, accredited industry certification programs should be used for every product to provide credibility and quality assurance for retail and carrier based customers looking to add ever increasing num...
Oct. 23, 2016 12:00 AM EDT Reads: 430
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
Oct. 23, 2016 12:00 AM EDT Reads: 1,821